Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Overweight Youth with Bipolar Disorder on Antipsychotics
NCT02515773Phase 4Completed
- Start
- Dec 2015
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in obesity and Overweight (2 arms). Primary endpoints: Change in BMI Z-score From Baseline to Month 6 in ITT Sample and Change in BMI Z-score From Baseline to Month 24 in ITT Sample. Started Dec 2015; status: completed.
02
Drugs
metformin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT02515773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02515773.